Advertisement
Advertisement
TMO
Thermo Fisher Scientific, Inc.
706.16
USDSponsored
+7.82
+1.12%
Nov 04, 15:59 UTC -5
Closed
After-Market
712.07
+5.91
+0.84%
Thermo Fisher Scientific, Inc. (TMO) Earnings
TMO Earnings Reports
Positive Surprise Ratio
TMO beat 37 of 43 last estimates.
86%
Next Report
Date of Next Report
Jan 27, 2027
Estimate for Q4 26 (Revenue/ EPS)
$12.98B
/$7.19
Implied change from Q3 26 (Revenue/ EPS)
+6.93%
/+7.63%
Implied change from Q4 25 (Revenue/ EPS)
+6.24%
/+9.44%
Thermo Fisher Scientific, Inc. earnings per share and revenue
On Oct 21, 2026, TMO reported earnings of 6.68 USD per share (EPS) for Q3 26, beating the estimate of 6.46 USD, resulting in a 3.29% surprise. Revenue reached 12.14 billion, compared to an expected 12.07 billion, with a 0.59% difference. The market reacted with a +0.97% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 7.19 USD, with revenue projected to reach 12.98 billion USD, implying an increase of 7.63% EPS, and increase of 6.93% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Edwards Lifesciences Corp
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.75
Actual
$0.80
Surprise
+5.40%
Waters Corp
Report Date
Nov 03, 2026 For Q3 26
Estimate
$4.03
Actual
$4.09
Surprise
+1.56%
Fresenius Medical Care AG
Report Date
Nov 03, 2026 For Q3 26
Estimate
$1.03
Actual
$0.57
Surprise
-44.87%
LivaNova PLC Ordinary Shares
Report Date
Nov 04, 2026 For Q3 26
Estimate
$1.07
Actual
$1.23
Surprise
+14.06%
Veracyte, Inc.
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.41
Actual
$0.51
Surprise
+21.78%
UFP Technologies Inc
Report Date
Nov 03, 2026 For Q3 26
Estimate
$2.73
Actual
$2.88
Surprise
+5.16%
Opko Health Inc.
Report Date
Nov 04, 2026 For Q3 26
Estimate
-$0.06
Actual
-$0.05
Surprise
+27.22%
PROCEPT BioRobotics Corporation Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
-$0.39
Actual
-$0.46
Surprise
-16.49%
Sight Sciences, Inc. Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.12
Surprise
+12.22%
Neuronetics, Inc. Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.02
Surprise
+77.60%
FAQ
What were Thermo Fisher Scientific, Inc.'s earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Thermo Fisher Scientific, Inc. reported EPS of $6.68, beating estimates by 3.29%, and revenue of $12.14B, 0.59% above expectations.
How did the market react to Thermo Fisher Scientific, Inc.'s Q3 2026 earnings?
The stock price moved up 0.97%, changed from $687.37 before the earnings release to $694.02 the day after.
When is Thermo Fisher Scientific, Inc. expected to report next?
The next earning report is scheduled for Jan 27, 2027.
What are the forecasts for Thermo Fisher Scientific, Inc.'s next earnings report?
Based on --
analysts, Thermo Fisher Scientific, Inc. is expected to report EPS of $7.19 and revenue of $12.98B for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.